3 completed, 1 not yet recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow SJ733: new trials by email Literature Review of SJ733 trials Research Report on SJ733
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria SJ733/TQ placebo, CQ/TQ Placebo, CQ/TQ - Malaria, Malaria Vivax | Phase 2 | Not yet recruiting | R. Kiplin Guy | 104 | 2026-12-01 | 2026-10-21 |
| Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria (+)-SJ000557733 (SJ733) - Malaria, Falciparum, Malaria, Vivax | Phase 2 | Completed | R. Kiplin Guy | 22 | 2021-04-14 | 2023-12-04 |
| SJ733 Induced Blood Stage Malaria Challenge Study (+)-SJ000557733 - Plasmodium Falciparum Malaria | Phase 1 | Completed | Medicines for Malaria Venture | 17 | 2016-09-13 | 2020-05-05 |
| First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor SJ733, Cobicistat - Malaria | Phase 1 | Completed | St. Jude Children's Research Hospital | 44 | 2016-03-01 | 2019-01-02 |
Malaria (2) · Malaria, Falciparum (2) · Malaria, Vivax (2)
R. Kiplin Guy (2) · Medicines for Malaria Venture (1) · St. Jude Children's Research Hospital (1)
Peru (2) · Australia (1) · United States (1)
Aditya H. Gaur, MD (1) · Alejandro L Cuentas, MD, PhD (1) · Alejandro L Cuentas,, MD, PhD (1) · Rodney K Guy, PhD (1)